Background
Douglas is a New Zealand-based contract development and manufacturing organisation (CDMO) known for its technical expertise in high-potency softgel and liquid formulations.
Douglas has a long-standing partnership with Elion as its trusted medical communications agency. As a medium-sized player in a crowded global market, Douglas stands out through its agility, scientific depth, and commitment to quality. To extend its international reach and attract like-minded partners, Douglas invests in targeted, strategic thought leadership articles designed to speak directly to decision-makers in biotech and pharma companies.
The Brief
Douglas engaged Elion to develop a series of high-impact thought leadership articles that would not only resonate with a global pharma audience, but also strategically showcase the company’s capabilities. Each article needed to offer real value to senior leaders – whether in regulatory, clinical, or commercial roles – while reinforcing Douglas’s credibility as a strategic, solutions-focused CDMO. We receive comprehensive briefs from the Douglas marketing team – the kind every comms agency dreams of – complete with clear messaging objectives, target audience detail, access to subject matter experts (SMEs), and preferred delivery tone.
Our Solution
Elion supports Douglas across the content creation process, working from topics, key messages, and supporting materials provided by the Douglas team. Each article begins with a discovery call with a Douglas SME – often a leader in technical, commercial, or regulatory roles. These conversations bring depth, nuance, and firsthand insight that elevate each piece beyond generic commentary.
From there, our writing team crafts a first draft, translating technical complexity into a clear, strategic narrative tailored to the target audience. Each article is reviewed internally by our experienced editors to ensure clarity, consistency, and tone before being delivered to Douglas for final approval.
With a steady cadence of delivery, Douglas can continually share insightful, evergreen content across its web, sales, and marketing channels.
Outcomes
Our work has helped to position Douglas as a credible strategic partner.
Each article delivers real value to pharma and biotech leaders, reinforcing Douglas’ expertise and distinct positioning in the CDMO landscape.
We’ve built a scalable content model.
Our collaborative, repeatable process ensures consistent, high-quality content ready for use across web, sales, and marketing channels.
We have a strong and trusted partnership.
Years of aligned goals have made Elion Douglas’ go-to partner for med comms, bringing complex topics to life and highlighting innovations in softgels, tech transfers, and the value of medium-sized CDMOs over larger giants.
Looking ahead
This partnership exemplifies what happens when a client brings clear intent and expertise, and a med comms partner brings sharp thinking and flawless execution.
As Douglas continues to expand its footprint in the global CDMO market, Elion remains their preferred comms partner for content that reflects their scientific leadership, commercial insight, and strategic value.
